Menveo

Pipeline

Status by Indication[3][1]

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Immunogenicity4 trials

Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population

Unknown status·SSt George's, University of London·Phase 4·NCT03682939·55 enrolled

Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old

Recruiting·EEyeGene Inc.·Phase 2/3·NCT07204457·1,123 enrolled

Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children

Not yet recruiting·GSK·Phase 2·NCT07320716·528 enrolled

Show 1 more trial

Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old

Completed·EEuBiologics Co.,Ltd·Phase 1·NCT05739292·60 enrolled

Adult1 trial

A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays

Completed·GSK·Phase 4·NCT02072525·359 enrolled

Vaccines1 trial

Comparison of Two Meningococcal ACWY Conjugate Vaccines

Completed·PPublic Health England·Phase 2/3·NCT01192997·91 enrolled

Malaria1 trial

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M

Active, not recruiting·UUniversity of Oxford·Phase 2·NCT07183371·360 enrolled

Immune Response1 trial

A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Completed·GSK·Phase 2·NCT02676895·74 enrolled

1 more indication

Diarrhoea1 trial

A Staged Phase I/II Observer-blind, Randomised, Controlled, Multi-country Study to Evaluate the Safety, Reactogenicity, and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against S. Sonnei and S. Flexneri, Serotypes 1b, 2a, and 3a, in Adults in Europe (Stage 1) Followed by Age De-escalation From Adults to Children and Infants, and Dose-finding in Infants in Africa (Stage 2)

Completed·GSK·Preclinical·NCT05073003·551 enrolled

Details

Drug Info

Related News